| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Mahdessian Ara | Chief Executive Officer, Director | C/O SERVICETITAN, 800 N. BRAND BLVD., SUITE 100, GLENDALE | /s/ Olive Huang, Attorney-in-Fact | 17 Jul 2025 | 0001908788 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | TTAN | Class A Common Stock | Conversion of derivative security | $0 | +42.7K | $0.00 | 42.7K | 16 Jul 2025 | By the AMKE Trust dated February 1, 2019 | F1 | |
| transaction | TTAN | Class A Common Stock | Sale | -$1.99M | -18K | -42.17% | $110.84 | 24.7K | 16 Jul 2025 | By the AMKE Trust dated February 1, 2019 | F2, F3 |
| transaction | TTAN | Class A Common Stock | Sale | -$2.7M | -24.4K | -98.8% | $110.84 | 295 | 16 Jul 2025 | By the AMKE Trust dated February 1, 2019 | F2, F4 |
| transaction | TTAN | Class A Common Stock | Sale | -$32.7K | -295 | -100% | $110.84 | 0 | 16 Jul 2025 | By the AMKE Trust dated February 1, 2019 | F2, F5 |
| transaction | TTAN | Class A Common Stock | Conversion of derivative security | $0 | +42.7K | $0.00 | 42.7K | 17 Jul 2025 | By the AMKE Trust dated February 1, 2019 | F1 | |
| transaction | TTAN | Class A Common Stock | Sale | -$2.03M | -18K | -42.3% | $112.51 | 24.6K | 17 Jul 2025 | By the AMKE Trust dated February 1, 2019 | F2, F6 |
| transaction | TTAN | Class A Common Stock | Sale | -$2.6M | -23.1K | -93.99% | $112.51 | 1.48K | 17 Jul 2025 | By the AMKE Trust dated February 1, 2019 | F2, F7 |
| transaction | TTAN | Class A Common Stock | Sale | -$167K | -1.48K | -100% | $112.51 | 0 | 17 Jul 2025 | By the AMKE Trust dated February 1, 2019 | F2, F8 |
| holding | TTAN | Class A Common Stock | 0.75 | 16 Jul 2025 | Direct |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | TTAN | Class B Common Stock | Conversion of derivative security | $0 | -42.7K | -0.86% | $0.00 | 4.9M | 16 Jul 2025 | Class A Common Stock | 42.7K | By the AMKE Trust dated February 1, 2019 | F1, F9, F10, F11, F12 | |
| transaction | TTAN | Class B Common Stock | Conversion of derivative security | $0 | -42.7K | -0.87% | $0.00 | 4.85M | 17 Jul 2025 | Class A Common Stock | 42.7K | By the AMKE Trust dated February 1, 2019 | F1, F9, F11, F12 | |
| holding | TTAN | Class B Common Stock | 3.29M | 16 Jul 2025 | Class A Common Stock | 3.29M | Direct | F9, F10 | ||||||
| holding | TTAN | Class B Common Stock | 185K | 16 Jul 2025 | Class A Common Stock | 185K | By AM 2025 GRAT | F9, F11 | ||||||
| holding | TTAN | Class B Common Stock | 185K | 16 Jul 2025 | Class A Common Stock | 185K | By KE 2025 GRAT | F9, F12 | ||||||
| holding | TTAN | Class B Common Stock | 429K | 16 Jul 2025 | Class A Common Stock | 429K | By KE 2024 GRAT | F9 | ||||||
| holding | TTAN | Class B Common Stock | 429K | 16 Jul 2025 | Class A Common Stock | 429K | By AM 2024 GRAT | F9 |
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
| Id | Content |
|---|---|
| F1 | Represents the conversion of Class B Common Stock into Class A Common Stock held of record by the Reporting Person. |
| F2 | The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on April 15, 2025. |
| F3 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $109.75 to $110.74. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| F4 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $110.75 to $111.74. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| F5 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $111.75 to $111.94. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| F6 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $111.40 to $112.39. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| F7 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $112.40 to $113.39. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| F8 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $113.40 to $113.61. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| F9 | The Class B Common Stock is convertible into an equal number of shares of Class A Common Stock at any time, at the holder's election. Each share of Class B Common Stock will convert automatically into one share of Class A Common Stock upon any transfer, whether or not for value, except for certain permitted transfers, or upon the occurrence of certain specified events, in each case as set forth in the Issuer's Amended and Restated Certificate of Incorporation. |
| F10 | Reflects the transfer of 23,804 shares of Class B Common Stock from the Reporting Person to the AMKE Trust following the vesting of restricted stock units June 24, 2025. Such transfer was exempt from reporting pursuant to Rule 16a-13. |
| F11 | Reflects the following: (i) the July 2, 2025 transfer of 185,366 shares of Class B Common Stock from the AMKE Trust to the Reporting Person; and (ii) the subsequent July 2, 2025 transfer of 185,366 shares of Class B Common Stock from the Reporting Person to the AM 2025 GRAT. Such transfers were exempt from reporting pursuant to Rule 16a-13. |
| F12 | Reflects the following: (i) the July 2, 2025 transfer of 185,366 shares of Class B Common Stock from the AMKE Trust to the Reporting Person's spouse; and (ii) the subsequent July 2, 2025 transfer of 185,366 shares of Class B Common Stock from the Reporting Person's spouse to the KE 2025 GRAT. Such transfers were exempt from reporting pursuant to Rule 16a-13. |